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E-mail address: balsin@hotmail.com (R.H. Bhogal)Hypoxia and hypoxia–reoxygenation (H–R) regulate human hepatocyte cell death by mediating the
accumulation of reactive oxygen species (ROS). Hepatocytes within the liver are organised into peri-
portal (PP) and peri-venous (PV) subpopulations. PP and PV hepatocytes differ in size and function.
We investigated whether PP and PV human hepatocytes exhibit differential susceptibility to hypoxic
stress. Isolated hepatocytes were used in an in vitro model of hypoxia and H–R. ROS production and
cell death were assessed using ﬂow cytometry. PV, and not PP hepatocytes, accumulate intracellular
ROS in a mitochondrial dependent manner during hypoxia and H–R. This increased ROS regulates
hepatocyte apoptosis and necrosis via a mitochondrial pathway. These ﬁndings have implications
on the understanding of liver injury and application of potential therapeutic strategies.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The functional unit of the liver is the acinus, which extends
from the portal venule along the sinusoids to the terminal hepatic
venule. The liver acinus in rodents extends for approximately 20
hepatocytes [1]. Peri-portal (PP) hepatocytes (zone 1) which are
near the portal venule tend to be of a smaller size than peri-venous
(PV) hepatocytes (zone 3) which are located near the terminal he-
patic vein [2]. Indeed, some studies deﬁne and isolate PP and PV
hepatocyte populations upon the basis of size [3]. Furthermore,
these studies have utilised the technique of ﬂuorescent-activated
cell sorting (FACs) to consistently differentiate between PV and
PP hepatocytes and study their metabolic function [4–6]. More-
over, these studies have demonstrated that these hepatocytes have
distinct and separate cellular functions [3,7].
There is a large body of evidence to support the concept of mor-
phological, biochemical and metabolic heterogeneity of small/PP
and large/PV hepatocytes [7–10]. Indeed, various functions have
been ascribed to speciﬁc zones of the liver acinus. Speciﬁcally, oxi-
dative metabolism, gluconeogenesis, urea synthesis and bile for-
mation are predominantly small/PP hepatocyte activities whereas
glutamine synthesis, xenobiotic metabolism and ketogenesis are
predominant functions of the large/PV hepatocytes [11,12].chemical Societies. Published by E
.
.Moreover, studies have shown these differences in hepatocyte
function are attributable to differences in the enzyme expression
[7,10].
These differences in hepatocyte function are also likely to be
important determinants in the evolution of liver injury. For in-
stance, in rodent models, it is well documented that following
ischaemic liver injury, hepatocyte cell death is predominantly ob-
served around the peri-venular region where the PV hepatocytes
are located [13]. The ischaemic injury, within the liver, is regulated
by the accumulation of intracellular reactive oxygen species (ROS)
[14]. However, whether small/PP and large/PV hepatocytes have
differential ROS accumulation during hypoxia and H–R is not
known. In particular, whether small/PP or large/PV human hepato-
cytes exhibit differential responses to hypoxia and H–R remains to
be ascertained.
Previous studies have utilised various techniques to investigate
the different functions of small/PP and large/PV hepatocytes. These
include retrograde digitonin perfusion of livers [8] and elutriation
[7]. However, FACS analysis allows discrimination between hepa-
tocyte subpopulations on the basis of size. Previous studies have
consistently shown that the PV hepatocytes are larger in size than
the PP hepatocytes [4–6]. Thus we used this latter approach to
investigate whether PP or small and PV or large human hepato-
cytes exhibit differential responses to hypoxia and hypoxia–reoxy-
genation (H–R). Speciﬁcally, we investigated whether small/PP and
large/PV human hepatocytes exhibit differential levels of ROSlsevier B.V. All rights reserved.
Fig. 1. The morphology and phenotype of isolated human hepatocytes. (a) Demon-
strates the phenotypic features characteristic of human hepatocytes isolated using
our protocol. The cell speciﬁcmarkers, cytokeratin 18, cytokeratin 19 and CD31were
determined using cell based ELISA as described in theMethods andMaterials section.
Human hepatocytes demonstrate a uniform staining for the hepatocyte speciﬁc
marker, cytokeratin 18. These cells show no staining for the biliary epithelial marker,
cytokeratin 19 or endothelial cell marker, CD31. In contrast, hepatic sinusoidal
endothelial cells show strong positivity for the marker CD31 and no positivity for
either cytokeratin 18 or cytokeratin 19. (b) Illustrates a representative image of
human hepatocytes following successful isolation. These cells have been allowed to
adhere to rat type 1 collagen for 2 h. There is a clear difference in size between the
isolated hepatocytes. As previous authors have shown the smaller hepatocytes are
likely to be derived from the peri-portal area and the larger hepatocytes are likely to
be derived from the peri-venous region [4–6].
936 R.H. Bhogal et al. / FEBS Letters 585 (2011) 935–941accumulation during hypoxia and H–R and whether this had an
impact upon apoptosis and necrosis.
2. Materials and methods
2.1. Human hepatocyte isolation
Liver tissue was obtained from fully consenting patients under-
going transplantation, hepatic resection for benign liver disease or
normal donor tissue surplus to surgical requirements. Liver tissue
was obtained from surgical procedures carried out at the Queen
Elizabeth Hospital, Birmingham, UK. Ethical approval for the study
was granted by the Local Research Ethics Committee (LREC) (refer-
ence number 06/Q702/61). Human hepatocytes were isolated
using a method that we have described previously [14]. Hepato-
cytes were isolated from fresh liver wedges weighing between 60
and 156 g using a two-step collagenase protocol. Liver wedges
were ﬁrst perfused with non-recirculating wash buffer (10 mM
HEPES pH 7.2) (Sigma, Dorset, UK) at 37 C using a ﬂow rate of
75 mL/min in order to remove the remaining blood within the li-
ver. After this, the wedge was perfused with a chelating solution
(non-recirculating) (10 mM HEPES, 0.5 mM EGTA, pH 7.2) (Sigma).
This was followed by further perfusion with [non-recirculating]
wash buffer to remove any remaining EGTA. Following this the tis-
sue was perfused with recirculating enzymatic dissociation solu-
tion (Hank’s Balanced Salt Solution (HBSS) (Gibco, Paisley, UK)
with calcium chloride (5 mM) (Sigma), magnesium chloride
(5 mM) (Sigma), 0.5% w/v collagenase (Roche, Hertford, UK),
0.25% w/v protease (Sigma), 0.125% w/v hyaluronidase (Sigma)
and 0.05% w/v DNase (Sigma)) at 37 C using a ﬂow rate 75 mL/
min for between 1 and 7 min. Following manual dissociation of
the liver wedge the suspension was passed through a nylon mesh
of 250 lm followed by a nylon mesh of 60 lm. Suspensions were
then washed at 50g for 10 min at 4 C in supplemented media
(Dulbecco’s Modiﬁed Eagle Medium (DMEM) (Gibco) with 10% v/
v heat inactivated foetal calf serum (Gibco), 2 mM glutamine (Gib-
co), 20,000 units/L penicillin and 20 mg/L streptomycin (Gibco)).
Immediately after washing cell viability was determined by trypan
blue dye exclusion. Hepatocytes were plated out in supplemented
media and left for 2 h. After this period, the media were changed to
Williams E media (Sigma) containing hydrocortisone (2 lg/ml),
insulin (0.124 U/ml), glutamine (2 mM), penicillin (20,000 units/
L) and streptomycin (20 mg/L). Cells were cultured for further
2 days prior to use. Only viable cells are able to adhere to rat type
1 collagen-coated plates and hence all cells were viable at the com-
mencement of the experiments.
Enzyme-linked immunosorbent assay (ELISA) of human hepato-
cytes and human hepatic sinusoidal endothelial cells (HSEC) for
Cytokeratin 18, Cytokeratin 19 and CD31were performed.
Cells (hepatocytes or HSEC) were plated on rat type 1 collagen-
coated 96-well ﬂat-bottomed plates for 24 h following isolation.
Cells were then ﬁxed in ice cold methanol for 5 min. Non-speciﬁc
binding of mAb was inhibited by pre-incubation of cells for 1 h
at 37 C with 4% goat serum (Sigma) before the addition of mouse
anti-human mAb (IgG Isotype-matched control (Invitrogen) CD31
(Dako), cytokeratin 19 (Dako), cytokeratin 18 (Invitrogen) for 1 h
at 37 C. The cells were then washed thoroughly before incubation
with peroxidase-conjugated goat anti-mouse secondary Ab (Dako).
The enzyme-linked immunosorbent assay (ELISA) was developed
using O-phenylenediamine substrate (OPD, Dako) according to
the manufacturer’s instructions and the enzymatic reaction was
stopped using 0.5 mol/L H2SO4 (Fisher Scientiﬁc, Leicestershire,
UK). Colorimetric analysis was performed by measuring absor-
bance values at 490 nm using a Dynatech Laboratories MRX plate
reader. All treatments were performed in triplicate for each
experiment.2.2. Model of hypoxia and H–R injury
We utilised a model of warm in vitro hypoxia and H–R that we
have described previously [14]. Brieﬂy, in experiments, hepato-
cytes were cultured for 2 days at 37 C, 5% CO2 in Williams E media
(Sigma) on rat type 1 collagen-coated plates. Hepatocytes were
either maintained in normoxia or placed into hypoxia for 24 h, or
placed into hypoxia for 24 h followed by 24 h of reoxygenation.
Hypoxia was achieved by placing cells in an airtight incubator
(RS Mini Galaxy A incubator, Wolf Laboratories, UK) ﬂushed with
5% CO2 and 95% N2 until oxygen content in the chamber reached
0.1%, as veriﬁed by a dissolved oxygen monitor (DOH-247-KIT,
Omega Engineering, UK). In preliminary experiments, human
hepatocytes were exposed to 5% and 1% oxygen and no increase
in ROS accumulation or cell death was noted. Therefore, we used
0.1% oxygen in all subsequent experiments for 24 h, similar to pre-
viously published studies. Additionally, Williams E media were
pre-incubated in the hypoxic chamber in a sterile container, which
allowed gas equilibration, for 8 h before experiments were carried
out, resulting in a ﬁnal oxygen concentration of <0.1% as measured
with the dissolved oxygen metre. Where appropriate, after 24 h of
hypoxia media were aspirated and replaced with fresh, warmed,
oxygenated medium, and the cells were returned to normoxic con-
ditions. This was deﬁned as the beginning of reoxygenation. In
experiments involving ROS inhibitors, reagents were made fresh
as stock solutions and added using the correct dilutional factor to
the relevant experimental wells. Speciﬁcally, 1 mM rotenone (Sig-
ma) was dissolved in chloroform and was diluted appropriately to
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none, solvent alone controls were used to ensure no vehicle effects
(data not shown). Rotenone was added at the time of placement of
the cells into conditions of hypoxia or reoxygenation.
2.3. Determination of human hepatocyte ROS accumulation and
apoptosis
ROS production, apoptosis and necrosis were determined by
using a three-colour reporter assay system. ROS accumulationFig. 2. Intracellular ROS accumulation within PP and PV human hepatocytes during
accumulation in PP and PV primary human hepatocytes during normoxia, hypoxia and H
forward scatter (FS) versus side scatter (SS) plot of primary human hepatocytes. The FS v
were obtained during normoxia and hypoxia (data not shown). The top panel shows the g
areas of interest on the ﬂow cytometric plots are marked by the vertical ellipses. The are
plot as human hepatocytes vary considerably in size and, therefore, to include all viable h
by necessity includes the cell debris. The bottom panel shows the gating protocol applie
chart with the pooled data of ﬁve separate experiments illustrating the accumulation o
separate experiments here as human hepatocytes isolated from separate livers (normal a
are based upon values taken from cells within the gated region shown in Fig. 1a. Data
hypoxia, ⁄⁄⁄P < 0.001 relative to normoxia, Mann–Whitney test).was determined using the ﬂuorescent probe 20,70-dichloroﬂuores-
cin-diacetate [14]. This probe is cell permeable and once inside
the cell is cleaved by intracellular esterases to 20,70-dichloroﬂuores-
cin (DCF) (Merck, Nottingham, UK) which is then rendered cell
impermeable. DCF is then able to react with intracellular ROS, spe-
ciﬁcally hydrogen peroxide, to give a ﬂuorescent signal detectable
on the FITC channel. The signal is directly proportional to the level
of intracellular ROS present.
Apoptosis was determined by labelling cells with Annexin-V
(Molecular Probes, Paisley, UK) which detects exposedhypoxia and H–R. (a) Demonstrates a representative ﬂow cytometry plot of ROS
–R. The plot on the left hand side of each ﬂow cytometric plot represents a typical
ersus SS plots shown is from the H–R sample of a liver preparation but similar plots
ating protocol applied to human hepatocytes to analyse PV human hepatocytes. The
a on the left of each ellipse represents cell debris. Cell debris is included within the
uman hepatocytes in the analysis a large gate is required on the ﬂow cytometre, this
d to human hepatocytes to analyse PP human hepatocytes (n = 5). (b) Shows a bar
f ROS within PV and PP human hepatocytes during hypoxia and H–R. We refer to
nd diseased), used in separate experiments. Data are expressed as MFI and readings
are expressed as mean ± S.E. (⁄P < 0.01 relative to normoxia, ⁄⁄P < 0.01 relative to
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D (7-AAD) (Molecular Probes, Paisley, UK) is a vital dye that binds
to DNA, only entering cells once the cell membrane is disrupted
and is indicative of cellular necrosis. To ensure consistency of the
ﬂow cytometric data, each human hepatocyte preparation was la-
belled with DCF alone, Annexin-V alone and 7-AAD alone to ensure
that cells had become labelled and that the ﬂow cytometry data
could be compensated for crossover of ﬂuorophore emission spec-
tra. The same ﬂow cytometre protocol was used for all experiments
shown within the study, meaning that voltages for all markers
were constant for all human hepatocyte preparation ensuring
internal consistency of experiments.
Following appropriate treatment of cells, media were aspirated
and replaced with HBSS (Gibco) without calcium and magnesium.
DCF (30 lM) was added and the cells were incubated for 20 min in
the dark at 37 C. Next the cells were trypinsed (0.05% with EDTA,
Gibco) for 5 min and washed extensively in FACs buffer (Phos-
phate-buffered saline pH 7.2 with 10% v/v heat inactivated foetal
calf serum (Gibco). Cells were then labelled with Annexin-V and
7-AAD for 15 min whilst on ice and samples were immediately
subjected to ﬂow cytometry. At least 20,000 events were recorded
within the gated region of the ﬂow cytometre for each human
hepatocyte cell preparation in each experimental condition. Only
the cells within the gated region were used to calculate mean ﬂuo-
rescence intensity (MFI).Fig. 3. Mitochondrial dependent ROS production in PV human hepatocytes during hypo
effect of rotenone (solid grey) upon PV human hepatocyte ROS accumulation during norm
by the vertical ellipses. The gating protocol applied to PV human hepatocytes is the s
represents cell debris. Fig. 3b shows a bar chart with the pooled data of ﬁve separate exp
accumulation during normoxia, hypoxia and H–R. Human hepatocytes were treated w
dissolved in chloroform to make a stock solution of 1 mM and diluted appropriately. Veh
Data are expressed as MFI and readings are based upon values taken from cells within the
basal, ⁄⁄P < 0.001 relative to basal).2.4. Statistical analysis
All data are expressed as mean ± S.E. Statistical comparisons be-
tween groups were analysed by using the Mann–Whitney test. All
differences were considered statistically signiﬁcant at a value of
P < 0.05.
3. Results
3.1. Isolated human hepatocytes exhibit typical features of
hepatocytes
The isolated human hepatocytes consistently showed typical
morphological and phenotypic features of hepatocytes (Fig. 1).
The cell preparations were uniformly positive for the speciﬁc intra-
cellular hepatocyte marker Cytokeratin 18 whilst demonstrating
no staining with the biliary epithelial cell marker Cytokeratin 19
of the hepatic sinusoidal endothelial cell (HSEC) marker CD31. In
contrast control HSEC demonstrates strong positivity for CD31
and no staining with Cytokeratin 18.
In addition, the isolated hepatocytes demonstrated consistent
heterogeneity in terms of size. Fig. 1b clearly shows that viable
intact cells were of two different size populations. As previous
studies have demonstrated the small hepatocytes are highly likely
to represent cells originating from the peri-portal region of thexia and H–R. (a) Demonstrates representative ﬂow cytometry plots to illustrate the
oxia, hypoxia and H–R. The areas of interest on the ﬂow cytometric plots are marked
ame as that shown within Fig. 2a. Once again, the area on the left of each ellipse
eriments illustrating the effects of 2 lM rotenone upon PV human hepatocytes ROS
ith 2 lM rotenone at the time of placement into hypoxia or H–R. Rotenone was
icle alone was shown not to have any effect upon ROS production (data not shown).
gated region shown in Fig. 2a. Data are expressed as mean ± S.E. (⁄P < 0.01 relative to
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venular region [4–6]. These data demonstrate that our isolation
technique yielded human hepatocytes of a high purity with little
or no contamination with other cell types and that using FACS
we could discriminate effectively between small/PP and large/PV
human hepatocytes.
3.2. Small (PP) and large (PV) human hepatocytes exhibit differential
ROS accumulation during hypoxia and H–R
FACs analysis was able to discriminate between large or PV
and small or PP human hepatocytes using appropriate forward
scatter (FS) and side scatter (SS) plots (Fig. 2). Accordingly, using
suitable ﬂow cytometric gating protocols the response of large/PV
and small/PP hepatocytes to hypoxia and H–R could be
ascertained.Fig. 4. PV human hepatocytes undergo apoptosis and necrosis during hypoxia and H–R. (
necrosis in PP and PV human hepatocytes during hypoxia and H–R. The gate used to an
interest within the ﬂow cytometric plots are marked by the vertical ellipses. (b) Shows a
apoptosis and necrosis in PP and PV human hepatocytes during hypoxia and H–R. Data a
apoptosis and necrosis during normoxia alone. Data are expressed as mean ± S.E. (P <
cytometry plots to illustrate the effects of rotenone upon the level of PV human hepatoc
used to analyse large human hepatocytes is the same as that shown in Fig. 2. The area
Shows a bar chart with the pooled data of ﬁve separate experiments illustrating the
normoxia, hypoxia and H–R. Data are expressed as increase/decrease relative to basal, w
are expressed as mean ± S.E. (P < 0.05 relative to no treatment in the same experiment
⁄⁄P < 0.001 relative to no treatment in the same experimental condition).PV hepatocytes, isolated from benign liver resections, normal
donor tissue and biliary cirrhosis (primary biliary cirrhosis and
primary sclerosing cholangitis) showed signiﬁcant increase in
ROS accumulation during hypoxia (Fig. 2a and b). Exposure of hu-
man hepatocytes to H–R further accentuated intracellular ROS
accumulation. In contrast, PP hepatocytes, showed no increase in
intracellular ROS accumulation during hypoxia and H–R.
3.3. ROS production in large (PV) hepatocytes is mitochondrial
dependent
Numerous previous studies have shown that the mitochondrion
is the central source of ROS during hypoxia and H–R [14–16].
Therefore, mitochondrial function was inhibited within large/PV
human hepatocytes using the complex I mitochondrial chain
inhibitor, rotenone. As Fig. 3a and b demonstrates, rotenonea) Shows representative ﬂow cytometry plots to illustrate the level of apoptosis and
alyse primary human hepatocytes are the same as that shown in Fig. 2. The area of
bar chart with the pooled data of ﬁve separate experiments illustrating the level of
re expressed as increase/decrease relative to basal, where basal refers to the level of
0.05 relative to basal, ⁄P < 0.01 relative to basal). (c) Shows representative ﬂow
yte apoptosis and necrosis during normoxia, hypoxia and H–R. The gating protocol
of interest within the ﬂow cytometric plots are marked by the vertical ellipses. (d)
effect of rotenone upon the level of PV hepatocyte apoptosis and necrosis during
here basal refers to the level of apoptosis and necrosis during normoxia alone. Data
al condition, ⁄P < 0.01 relative to no treatment in the same experimental condition,
Fig. 4 (continued)
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cytes during normoxia, hypoxia and H–R. Rotenone had no effect
upon ROS accumulation in small/PP human hepatocytes (data not
shown).
3.4. Large (PV) and not small (PP) human hepatocytes undergo
apoptosis and necrosis during hypoxia and H–R
The relationship between intracellular ROS accumulation and
apoptosis and necrosis has been clearly established within human
hepatocytes [14]. Accordingly, we found that large/PV human
hepatocytes, in line with their propensity to generate ROS during
hypoxia and H–R, underwent signiﬁcant levels of apoptosis and
necrosis (Fig. 4a and b). In contrast, small/PP hepatocytes did notundergo any apoptosis or necrosis in line with their lack of ROS
generation during hypoxia and H–R. We ﬁnally investigated
whether mitochondrial generated ROS during hypoxia and H–R
was responsible for regulating human hepatocyte apoptosis and
necrosis. As Fig. 4c and d illustrates, rotenone signiﬁcantly reduces
large/PV human hepatocyte apoptosis and necrosis during nor-
moxia, hypoxia and H–R. These ﬁndings clearly demonstrate that
in PV human hepatocytes mitochondrial ROS generated during hy-
poxia and H–R drives cell death.
4. Discussion
Exposure of hepatocytes to pathological conditions in a micro-
environment of hypoxia and H–R is very frequent in several hepa-
R.H. Bhogal et al. / FEBS Letters 585 (2011) 935–941 941tic diseases and hepatic surgery. These include haemodynamic
shock, septicaemia and liver transplantation. Death of hepatocytes
by hypoxia and H–R injury is a multifactorial event including alter-
ation of the plasma membrane, increase of autophagic vacuoles,
rupture of blebs on the cell surface, calcium accumulation and
mitochondrial damage [9]. The common mediator of these death
pathways appears to be the accumulation of ROS [17]. Studies in
rodent models suggest that large/PV hepatocytes are more vulner-
able to damage during hepatic injury [8]. Moreover, hepatocyte
proliferation, which is an important determinant of patient
survival after major hepatic resection, occurs from the small/PP
to large/PV hepatocytes. Therefore, an understanding of the differ-
ential vulnerability of hepatocytes to liver injury would provide an
important basis for preventing loss of liver function and/or failure
caused by cirrhosis, hepatic resection and liver transplantation [8].
Common factors to most liver injuries are hypoxia and the gener-
ation of ROS [14,17]. However, the susceptibility of hepatocytes,
and in particular human hepatocytes, to oxidative stress has not
been assessed directly. We show for the ﬁrst time to our knowl-
edge, clear evidence that large/PV hepatocytes are the most sus-
ceptible to hypoxic injury. Moreover, this susceptibility is due to
the greater propensity of the mitochondria of these large/PV hepa-
tocytes to produce and accumulate intracellular ROS [18]. It must
be noted however, that inhibiting mitochondrial function does
not completely abrogate large/PV human hepatocyte apoptosis
and necrosis. Indeed, previous studies have shown that other en-
zymes involved in ROS generation are also involved in regulating
human hepatocyte apoptosis [14].
The increased level of apoptosis and necrosis seen in large/PV
human hepatocytes seen in vitro in the present study would con-
cur with in vivo models of murine and rodent liver injury, where
cell death is observed in the peri-venular regions of the liver
[13]. A possible explanation for this observation may well be that
the powerful antioxidant glutathione (in rodent models) varies
considerably in concentration between hepatocytes isolated from
the small/PP and large/PV regions [19]. Speciﬁcally, large/PV hepa-
tocytes have less intracellular glutathione when compared to
small/PP or small hepatocytes. Moreover, following stimulation
with amino acids larger hepatocytes are able to generate less intra-
cellular glutathione than small hepatocytes [19]. These ﬁndings
could in theory explain the increased susceptibility of large/PV hu-
man hepatocytes to hypoxic injury.
Previous studies have shown that mitochondrial inhibitors and
anti-oxidants inhibit ROS accumulation in human hepatocytes dur-
ing hypoxia and H–R [14–16]. Our present study builds upon this
observation, demonstrating that mitochondrial electron transport
chain inhibitors speciﬁcally reduce ROS accumulation in the
large/PV hepatocytes and consequently reduce apoptosis in this
population during hypoxia and H–R. Many studies have suggested
that resident liver macrophages (Kupffer cells) located in the PV re-
gion of liver are activated during ischaemia and release ROS, lead-
ing to hepatocyte damage [8]. Taken together with our study this
suggests that the PV region of the liver is the preferential site of he-
patic inﬂammation and ROS generation during hypoxic liver injury.
Contrastingly, some studies in rodent hepatocytes have suggested
that small/PP hepatocytes are more vulnerable to hypoxic injury
due to their higher requirement of oxygen [8]. We remain uncer-
tain about the explanation for these discrepancies which may rep-
resent inter-species differences of unknown aetiology.
In conclusion, large/PV human hepatocytes are the most sus-
ceptible to hypoxic damage. This suggests that therapeutics usedin the treatment of liver disease may primarily act upon PV or large
human hepatocytes. In the future, therapeutic strategies used to
treat hepatic inﬂammationmay require novel drug targeting meth-
ods that allow the delivery of the drug preferentially to the PV or
large hepatocytes.Acknowledgements
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